Saltwater olives(ter in a commercial orchard simulation s...)
Navigation Links
Saltwater olives
Date:7/17/2008
ter in a commercial orchard simulation study in a semiarid area", stated Weisman.
Olive trees in both subplots were evaluated for trunk growth, olive yield, oil percentage, olive oil yield, and other characteristics. The data clearly showed a significant difference between the tested cultivars in terms of growth, yield, and oil parameters. Researchers concluded that all the tested olive varieties could be cultivated with moderate saline water irrigation. Weisman added: "Although a significant variation in terms of horticultural performance was found between the various tested olive cultivars, the differences may be attributed to the natural characteristics of each cultivar or to their rate of adaptation to the environmental conditions in the tested area, rather than to moderate saline drip irrigation."
'/>"/>
| Contact: Michael W. Neff mwneff@ashs.org 703-836-4606 American Society for Horticultural Science Source:Eurekalert |
Related biology news :
1. Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations
2. Saltwater crocodiles can find their way home
3. A compound extracted from olives inhibits cancer cells growth and prevents their appearance
Post Your Comments:
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4Brooding fishes take up nutrients from their own children 2Plate-eating good: Université de Montréal professor designs edible tableware 2The Worlds First Goodyear Concept Tires Made with BioIsoprene 28TM 29 Technology Arrive in Copenhagen in time for United Nations Climate Change Confer 15049 1The Worlds First Goodyear Concept Tires Made with BioIsoprene 28TM 29 Technology Arrive in Copenhagen in time for United Nations Climate Change Confer 15049 2The Worlds First Goodyear Concept Tires Made with BioIsoprene 28TM 29 Technology Arrive in Copenhagen in time for United Nations Climate Change Confer 15049 3Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 1Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 2Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 3Caltech scientists show how ubiquitin chains are added to cell cycle proteins 62471 4Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 62467 1Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 62467 2
Other Biology News:Global trade in tiger shrimp threatens environment 2World's largest marine protected area created in Pacific Ocean 2World's largest marine protected area created in Pacific Ocean 3Story tips from the Department of Energy's Oak Ridge National Laboratory, February 2008 2Story tips from the Department of Energy's Oak Ridge National Laboratory, February 2008 3
Breaking Biology Technology:Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2
[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea[0] Waters Ships First Units of SYNAPT G2 Mass Spectrometer[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas[0] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property
Other Biology Technology:China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xi'an Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009 2China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xi'an Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009 3China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xi'an Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009 4China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xi'an Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009 5Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc. 2Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc. 3ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products 2ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products 3
China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xi'an Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.ZyGEM and Advalytix Partner to Produce Innovative DNA Extraction Products
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |